Ostera By Metagenics Overview & Drug Interactions

Check For Interactions With Ostera

Supplement: Ostera by Metagenics

Ostera Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Ostera by Metagenics

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Tablet(s)
Maximum serving Sizes:
1 Tablet(s)
Servings per container 60
UPC/BARCODE 755571918765

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Vitamin D
500 IU
Vitamin D 125%
Vitamin K
500 mcg
Vitamin K (unspecified) 625%
Berberine HCl
90 mg
Berberine --
Reduced Iso-Alpha Acids Complex
370 mg
Alpha acids --

Other Ingredients:
Microcrystalline Cellulose
Stearic Acid
Croscarmellose Sodium
Calcium Silicate
Silica
Coating
Forms
  • Hydroxypropylcellulose
  • Hypromellose
  • Medium Chain Triglycerides
  • Water


Label Statments:


Brand IP Statement(s)
- In a clinical study of postmenopausal women with low estrogen levels, Ostera(TM)-in conjunction with a modified Mediterranean, low glycemic diet and regular exercise-was shown to beneficially influence key markers of bone remodeling more than diet and exercise alone. Bone remodeling is the natural process of healthy breakdown and formation of the bone matrix-the structure where minerals are deposited. This scientifically advanced formula features selective kinase response modulators (SKRMs) in the form of RIAA, as well as the herb berberine, and vitamins D and K to nutritionally support healthy bone remodeling during the aging process.
Suggested/Recommended/Usage/Directions
- Recommended for use with Cal Apatite(R)-an advanced bioactive formulation for bone mineralization.
- DIRECTIONS: Take one tablet twice daily, or as directed by your healthcare practitioner.
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Storage
- STORAGE: Keep tightly closed in a cool, dry place.
Formulation
- This product is Gluten Free.
General Statements
- Genetic Potential Through Nutrition
- with Selective Kinase Response Modulators
- LST037C2
- 0610088 8/12
- PROD. OSTEO60
Seals/Symbols
- UNLEASHING THE POWER OF NUTRAGEMICS ExpressSyn(TM)
Formula
- Promotes Healthy Bone Remodeling in Postmenopausal Women
FDA Statement of Identity
- Dietary Supplement
Precautions
- WARNING: Do not use if pregnant or nursing or if taking cyclosporine or anticoagulant medication.
- CAUTION: If taking other medication, consult your healthcare practitioner before use.
- Keep out of the reach of children.

Brand Information

See all products by this brand

Developed and Manufactured by
Name METAGENICS, INC. Makers of Professional Quality Supplements
Street Address 100 Ave. La Pata
City San Clemente
State CA
ZipCode 92673
Web Address www.metagenics.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.